Phase I/II Lapatinib Plus Carboplatin and Paclitaxel in Stage III or IV Relapsed Ovarian or Stage IV Breast Cancer Patients.
Phase of Trial: Phase I/II
Latest Information Update: 17 Feb 2011
At a glance
- Drugs Carboplatin; Lapatinib; Paclitaxel
- Indications Advanced breast cancer; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 17 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Feb 2011 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 09 Mar 2010 Planned end date changed from Jan 2009 to Jan 2011 as reported by ClinicalTrials.gov.